BMC Medical Unveils Innovations in Respiratory and Sleep Care at ERS 2025 in Amsterdam

BMC Medical Unveils Innovations in Respiratory and Sleep Care at ERS 2025

From September 28 to October 1, 2025, Amsterdam will host the European Respiratory Society’s (ERS) annual congress, where BMC Medical, a leading global provider of respiratory and sleep solutions, is set to present its latest innovations. With a focus on patient-centered care and clinical decision-making, BMC Medical aims to transform the landscape of respiratory treatment.

Cutting-Edge Product Launches

At booth H.13 in Hall 1, BMC Medical will unveil three significant product innovations:

1. 6S Series Mask: This next-generation mask is designed with enhanced comfort and fit, ensuring improved adherence for patients. By addressing common issues faced by users, the 6S series is expected to enhance the overall patient experience and efficacy of respiratory therapies.

2. G3 A20 CPAP Device: Offering enhanced adaptability and customization, the G3 A20 CPAP device optimizes treatment outcomes for patients dealing with sleep apnea. This device represents a significant step forward in allowing healthcare professionals to tailor interventions based on individual patient needs.

3. Home Sleep Testing Devices: The introduction of the YH-S900C and YH-S900B portable diagnostic tools enables accessible and accurate sleep testing in the comfort of patients' homes. These devices are poised to revolutionize the way patients are diagnosed and monitored for sleep disorders, ensuring timely and effective treatment.

Engaging Workshops and Expert Discussions

In addition to the product showcase, BMC Medical is sponsoring a workshop titled "The Future of CPAP Monitoring: What Needs Changing Today?" scheduled for Tuesday, September 15, from 14:00 to 14:45 in Room E103-104. This session will feature leading experts such as Dr. Renata Riha from the University of Edinburgh and Professor Jean-Louis Pépin from the University Hospital of Grenoble. The discussion will be moderated by Dr. Ding Zou and Dr. Abdelkebir Sabil, Global Medical Director at BMC.

The workshop will focus on evolving from a one-size-fits-all adherence goal of "4 hours/night" towards a more nuanced, phenotype-driven management approach aimed at optimal outcomes. Key aspects of the discussion will include integrating remote monitoring, artificial intelligence, and multimodal data to enhance patient outcomes and reduce cardiovascular risk.

Commitment to Respiratory Health

Founded in 2001, BMC Medical has dedicated itself to partnering with families worldwide to mitigate the challenges posed by chronic respiratory diseases. Through high-quality products, professional services, and proactive care strategies, the company has established itself as a trusted entity within the healthcare sector.

With these new innovations and a commitment to excellent care, BMC Medical plans to make a notable impact at ERS 2025, paving the way for improved respiratory health management in the years to come.